Stacey Seltzer

Photo of Stacey Seltzer, Partner at Aisling Capital
CompanyDeal TypeAmountDate
Aimmune TherapeuticsSeries B$80M (Lead)Mar 2015
Agile TherapeuticsPost-IPO Equity$20MFeb 2015
No media found for Stacey Seltzer.
cb
Photo of Aftab Kherani, Partner at Aisling Capital

Aisling Capital

Photo of Andrew Schiff, Managing Partner at Aisling Capital

Aisling Capital

Photo of Ayman Sabi, Partner at Aisling Capital

Aisling Capital

Photo of Dennis Purcell, Aisling Capital

Aisling Capital

Photo of Dov Goldstein, Managing Partner at Aisling Capital

Aisling Capital